Quantitative MRI in myositis patients: comparison with healthy volunteers and radiological visual assessment by Farrow, Matthew et al.
lable at ScienceDirect
Clinical Radiology 76 (2021) 81.e1e81.e10Contents lists avaiClinical Radiology
journal homepage: www.cl inicalradiologyonl ine.netQuantitative MRI in myositis patients:
comparison with healthy volunteers and
radiological visual assessment
M. Farrowa,b,c, J.D. Biglands b,d, A.J. Grainger e, f, P. O’Connor a,b,
E.M.A. Hensor a,b, A. Ladas g, S.F. Tanner b,d, P. Emery a,b, A.L. Tan a,b,*
a Leeds Institute of Rheumatic and Musculoskeletal Medicine, Chapel Allerton Hospital, University of Leeds, UK
bNIHR Leeds Biomedical Research Centre, Leeds Teaching Hospitals NHS Trust, Leeds, UK
c School of Pharmacy and Medical Sciences, University of Bradford, UK
dMedical Physics and Engineering, Leeds Teaching Hospitals NHS Trust, Leeds, UK
eDeprtment of Radiology, Cambridge University Hospital, Cambridge, UK
fAcademic Department of Radiology, University of Cambridge, UK
g Imperial College Healthcare NHS Trust, Charing Cross Hospital, London, UKarticle information
Article history:
Received 24 April 2020
Accepted 21 August 2020* Guarantor and correspondent: A. L. Tan, Leeds
þ44 113 392 4858.
E-mail address: A.L.Tan@leeds.ac.uk (A.L. Tan)
https://doi.org/10.1016/j.crad.2020.08.022
0009-9260/ 2020 The Royal College of Radiologists.
licenses/by-nc-nd/4.0/).AIM: To assess whether magnetic resonance imaging (MRI)-based measurements of T2, fat
fraction, diffusion tensor imaging, and muscle volume can detect differences between the
muscles of myositis patients and healthy controls, and to identify how they compare with
semi-quantitative MRI diagnosis.
MATERIALS AND METHODS: Sixteen myositis patients and 16 age- and gender-matched
healthy controls underwent MRI of their thigh. Quantitative MRI measurements and radiolo-
gists’ semi-quantitative scores were assessed. Strength was assessed using an isokinetic
dynamometer.
RESULTS: Fat fraction and T2 values were higher in myositis patients whereas muscle volume
was lower compared to healthy controls. There was no difference in diffusion. Muscle strength
was lower in myositis patients compared to healthy controls. In a subgroup of eight patients,
scored as unaffected by radiologists, T2 values were still significantly higher in myositis
patients.
CONCLUSIONS: Quantitative MRI measurements can detect differences between myositis
patients and healthy controls. Changes in the muscles of myositis patients, undetected by vi-
sual, semi-quantitative scoring, can be detected using quantitative T2 measurements. This
suggests that MRI T2 values may be useful for the management of myositis patients.
 2020 The Royal College of Radiologists. Published by Elsevier Ltd. This is an open access
article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).Institute of Rheumatic and Musculoskeletal Medicine, Chapel Allerton Hospital, University of Leeds, UK. Tel.:
.
Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/
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Idiopathic inflammatory myopathies (IIM), representing
forms of myositis, are a heterogeneous group of diseases
affecting approximately 5,000e6,000 people in the UK.1
Dermatomyositis (DM) and polymyositis (PM) are two
common types of myositis. They are characterised by
muscle pain and weakness, with overlapping features and
often present with the same autoantibodies.2 Myositis
predominantly manifests in skeletal muscle, with features
of inflammation, fatty infiltration, muscle atrophy, and al-
terations in muscle microstructure.3 The symptoms of
myositis often result in a severe impairment in quality of
life,4,5 and are associated with increased mortality.6 The
diagnosis and monitoring of myositis is reliant on clinical
examination, invasive muscle biopsies, blood tests, and
subjective muscle tests.
Imaging is frequently used to aid in the diagnosis and
monitoring of myositis,7 with visual scoring based on
magnetic resonance imaging (MRI) playing a key role in the
assessment of muscle oedema, fatty infiltration, and atro-
phy.8 An important role of imaging is the identification of
sites of muscle inflammation, which can then be targeted
for muscle biopsy.9 Currently, this is usually done by sub-
jective visual assessment of the muscle, a technique that
may be relatively insensitive to systemicmuscle changes. As
an alternative, there are a range of quantitative MRI tech-
niques that can detect subtle muscle changes in muscle
diseases and may have a role in the future clinical man-
agement of DM and PM, and the identification of sites for
biopsy and the monitoring of response to treatment.10e14
Quantitative T2 measurements are sensitive to fluid
related to physiological or pathological changes at the
macromolecular level15 andmay have a role in the long-term
follow-up of muscle oedema and inflammation.16 MRI-based
fat fraction (FF) measurements in the muscle are useful for
identifying fatty infiltration.17,18 Recently, interest has grown
regarding diffusion tensor imaging (DTI) techniques in the
muscle, which are sensitive to changes in muscle micro-
structure.11,19,20 All of these measurements have been shown
to have excellent intra- and inter-rater variability.21
There are few studies investigating these measurements
in myositis and, to the authors’ knowledge, this is the first
study to apply all these MRI techniques to a group of
myositis patients and to compare with current semi-
quantitative radiologist scoring. The aims of this study
were to compare FF, T2, muscle volume, and DTI diffusion
measurements in themuscle betweenmyositis patients and
a directly matched healthy population, and to compare
quantitative MRI measurements with radiologist’s scores
and muscle strength.Materials and Methods
Study design
This observational, caseecontrol study was approved by
the local research ethics committee (17/EM/0079). Allparticipants were 18 years of age and above with no con-
traindications to MRI and provided informed written con-
sent. Recruitment began in May 2017 and ended in July
2018.1:1 matching was used (matching the patient with a
healthy control of the same gender and within a 5-year age
range). The inclusion criteria for patients were based on the
Bohan and Peter criteria for myositis.3,22 Patients also ful-
filled the 2017 EULAR/ACR criteria for IIM for DM or PM,
which was published after the start of the study.23 Myositis
patients were included in the study if they were clinically
suspected of being active at the time of recruitment, with
muscle weakness and elevated creatinine kinase (CK; >200
IU/l in females and >320 IU/l in males), or had clinically
diagnosed muscle weakness, antibody positive, on treat-
ment for myositis, and had a patient global visual analogue
score (VAS) of >20/100 mm. These eligibility criteria have
been used in previous studies.24,25 Healthy controls were
included if they were asymptomatic with no history of
muscle disease. Clinical information was collected,
including CK, antibody status, and medication.
MRI measurements
MRI data were acquired using a MAGNETOM Verio 3T
MRI machine (Siemens Healthcare, Erlangen, Germany;
Table 1). The imaging protocol has been described previ-
ously.26 Images of the dominant thigh (the right if the
participant was unsure) were acquired using two small
four-channel flex coils.
All quantitative images were aligned to each other and
acquired with the same field of view to enable cross-
propagation of regions of interest (ROIs). For fat quantita-
tion a 40-section, volume-interpolated breath-hold exami-
nation (VIBE), two-point Dixon sequence was used.21
Diffusion-weighted images were acquired using a STEAM
prototype sequence, with an echo-planar imaging (EPI)
readout27 and SPAIR (spectral adiabatic inversion recovery)
fat suppression.21
For T2 measurements, axial images were obtained using
a T2-weighted, multi-echo, spin-echo (MESE) sequence
with SPAIR fat suppression with an echo train length of 16.
FF values were calculated from the fat and water images
generated from the VIBE Dixon images for each ROI. To
calculate T2 values the signal intensity versus echo time
decay curves from each ROI were fitted using a mono-
exponential decay function. To reduce the effect of addi-
tional signal from stimulated echoes the signal from the
earliest time point was excluded from the fit.28 Diffusion-
weighted images (DWI; Fig 1) were converted to MD, FA,
and eigenvalue maps using the vendor’s software.
Muscle volume estimates were obtained using a semi-
automated algorithm.26 The algorithm segmented muscle
from the FF maps generated by the VIBE Dixon analysis
using a FF threshold of <50%.
ROIs were contoured using Osirix imaging software
(version 4.0; open-source DICOM viewer, www.osirix-
viewer.com). Regions depicting the individual hamstring
muscles (semitendinosus, semimembranosus, and biceps
femoris) and quadriceps muscles (rectus femoris, vastus
Table 1
Magnetic resonance imaging sequence methodology.
Fat
quantification
T1
weighted
T2 Diffusion
Imaging sequence Two-point
VIBE Dixon
Turbo
spin-
echo
(TSE)
Multi-echo,
multi-
section
(MESE)
STEAM-
EPI
Repetition time 11 697 1,500 6,300
Echo time (ms) 2.45 and
3.675
9.1 9.6, 9.4,
153.6 (16
echoes)
42.4
Field of view (mm) 300300 300300 300300 300300
Section thickness (mm) 5 5 5 5
Fat suppression N/A STIR SPAIR SPAIR
Acquisition matrix 256256 256256 256256 128128
Number of sections 40 60 4 4
Number of averages 1 1 1 8
Receiver bandwidth
(Hz/pixel)
510 222 510 1,502
Flip angle (degrees) 15 90 15 -
Generalised auto
calibrating partial
parallel acquisition
(GRAPPA)
- - 2 (24
reference
lines)
Partial Fourier - - 6/8
B values (s/mm2) - - 0, 500
Directions - - 6
Mixing time (Tm) (ms) - - 981
Diffusion time (D; ms) - - 1,000
Acquisition time
(min:s)
2:19 2:05 6:12
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drawn on the middle section of the in-phase VIBE Dixon
volume for each participant, avoiding fascial tissue and
subcutaneous fat (Fig 1). ROIs were copied to the corre-
sponding FF, T2, and diffusion parameter maps, accounting
for differences in image resolution, and the mean valueFigure 1 (a) Dixon fat and (b) T2-STIR MRI images as reported by radiolog
and (d) T2-STIR iamges of a myositis patient with scored unaffected musc
STIR image in a healthy participant (right thigh). (g) ROIs: RF, rectus femor
biceps femoris; ST, semitendinosus; SM, semimembranosus.within each ROI was measured. The quantitative MRI sec-
tion analysed corresponded to the central section (sec-
tion20) of the VIBE Dixon muscle volume.
As ROIs depicting the whole muscle cross-section were
used in this study, both fatty infiltration and oedema may
be present within the same ROI. These two pathologies may
have opposite influences on DTI measures, so that if both
oedema and fat are present in the same ROI, the effects can
oppose each other and reduce the sensitivity of the measure
to disease.11 Therefore, in a subgroup analysis, nine patients
were identified: three with fatty-infiltrated regions, three
with oedematous regions, and three with unaffected re-
gions. One identical 5 mm circular ROI was placed within
either a fatty infiltrated, oedematous, or unaffected muscle
region respectively. DTI measurements in these three
separate regions were then compared (Electronic
Supplementary Material Fig. S1).
Muscle strength analysis
Knee extension (quadriceps) and flexion (hamstrings)
isokinetic assessment of the dominant thigh were per-
formed following MRI. The muscle strength testing protocol
has been described previously.26 Participants performed
three maximum effort repetitions for three sets, separated
by a 30-second rest interval. Power (Watts) was the
assessed variable. Handgrip strength, of their dominant
hand, was also measured using a Jamar plus isokinetic
dynamometer.
Radiologist semi-quantitative scoring
To compare with semi-quantitative radiologist scoring,
the muscles of the hamstrings and quadriceps were scored
on a four-point visual scale as either unaffected (0), mild1:ists in a myositis patient with affected muscle (left thigh). (c) Dixon fat
le (but elevated quantitative T2; right thigh). (e) Dixon fat and (f) T2-
is; VL, vastus lateralis; VM, vastus medialis; VI, vastus intermedius; BF,
Table 2
Quantitative MRI and strength measurements of scanned muscles for der-
matomyositis and polymyositis patients and healthy controls.
Mean (SD)
Hamstrings Quadriceps
T2 (ms) Myositis 47.8 (7.7) 53.8 (12.1)
Healthy 39.9 (1.5) 42.1 (2.1)
Fat fraction (%) Myositis 10.7 (9.4) 11.1 (13.1)
Healthy 4.1 (1.2) 2.7 (1.1)
Muscle volume (cm3) Myositis 1152 (594)
Healthy 1468 (331.4)
Mean diffusivity (103 mm2/s) Myositis 1.29 (0.1) 1.31 (0.1)
Healthy 1.32 (0.1) 1.34 (0.1)
Fractional anisotropy Myositis 0.41 (0.004) 0.36 (0.03)
Healthy 0.39 (0.1) 0.34 (0.1)
Eigenvalue 1 (103 mm2/s) Myositis 1.93 (0.1) 1.86 (0.1)
Healthy 1.91 (0.1) 1.84 (0.1)
Eigenvalue 2 (103 mm2/s) Myositis 1.09 (0.1) 1.16 (0.1)
Healthy 1.13 (0.2) 1.18 (0.2)
Eigenvalue 3 (103 mm2/s) Myositis 0.86 (0.1) 0.94 (0.1)
Healthy 0.89 (0.1) 0.98 (0.1)
Peak torque flexion (Nm) Myositis 32.8 (23) N/A
Healthy 57.2 (26) N/A
Peak torque extension (Nm) Myositis N/A 53.4 (46)
Healthy N/A 101.6 (45)
N/A, not applicable.
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involved, or severe3: >66% of muscle involved. Two radi-
ologists scored the muscles across the entire thigh using the
T2-weighted short tau inversion recovery (STIR) images (3
minutes 18 seconds acquisition time [TA], 6,550 ms, 87 ms
echo time [TE]) to identify muscle oedema and T1-weighted
images (1 minute 21 seconds TA, 658 ms repetition time
[TR], 8.8 ms TE) to identify fatty infiltration. If there was
disagreement between scores, these were resolved on
consensus following joint review.
Hamstrings and quadriceps scores were derived from the
mean of the individual muscle scores and rounded to the
nearest integer. The radiologists were blinded to other
clinical, laboratory, quantitative MRI, and muscle function
results. Patients who were scored as unaffected by the ra-
diologists (n¼8) were then compared with a matched
subgroup of healthy controls as a separate sub-study.
Statistical analyses
Offline image analysis was performed using MATLAB
software (R2018b, Mathworks, Natick, MA, USA). Statistical
analyses were performed using SPSS (Version 25.0. IBM,
Armonk, NY, USA). Paired samples t-tests were used to test
for differences in MRI measurements between patients and
healthy controls. Spearman’s rank correlation was used to
measure correlation; rs values 0.3 were considered
indicative of potential association, and p-values reported to
identify significance. Receiver operator characteristic (ROC)
curves were generated to assess diagnostic performance.
Cohen’s delta (d) has been provided for key comparisons,
with effect sizes interpreted as small (d¼0.2), medium
(d¼0.5), or large (d¼0.8).
Results
Sixteen myositis patients were recruited (10/16 female,
10 polymyositis, six dermatomyositis, mean age 5026,
mean height 16510 cm, mean weight 77.18 kg, mean
body mass index [BMI] 254), median CK of 1,000 IU/l
(range 70e12,802). The mean disease duration for the
myositis patients was 5 years (range 1 monthe22 years).
Five of the 16 (31%) myositis patients were positive for the
anti-Jo-1 antibody. The following myositis associated anti-
bodies were recorded as anti-PM-Scl 75 (2/16, 13%), anti-
PM-Scl 100 (2/16, 13%), anti-PL 12 (1/16, 6%). Other con-
nective tissue disease associated antibodies included anti-
Ro (5/16, 31%), anti-La (1/16, 6%), anti-Sm/RNP (3/16, 19%),
anti-chromatin (3/16, 19%), anti-centromere (1/16, 6%). Four
patients tested negative for antibodies. At the time of the
study, the patients were on the following therapies: pred-
nisolone: 9/16 (56%), hydroxychloroquine: 4/16 (25%),
methotrexate: 3/16 (19%), rituximab: 2/16 (13%), intrave-
nous immunoglobulins: 2/16 (13%), cyclophosphamide: 2/
16 (13%), mycophenolate mofetil: 2/16 (13%), azathioprine:
1/16 (6%). Most of the patients were receiving a combina-
tion of some of the above therapies, one patient was newly
diagnosed and yet to receive any therapy at the time of the
MRI. Sixteen age- and gender-matched healthy controlswere recruited (mean height 1679 cm, mean weight
7411 kg, mean BMI 262).
Within the hamstrings, the mean peak torque in the
myositis patients was lower than healthy controls by e24.4
Nm (95% confidence interval [CI]: e42.4, 6.4 Nm; p¼0.01).
Within the quadriceps, the mean peak torque in the pa-
tients was lower by e48.2 Nm (95% CI: e79.9, e22.2 Nm;
p<0.001). Descriptive data for quantitative MRI and muscle
strength is reported in Table 2.
The ROC curves and area under the ROC curve (AUC)
values for the quantitative measures are shown in Fig 2.
Considering the individual muscles that make up the
hamstrings and quadriceps (semitendinosus, semi-
membranosus, biceps femoris, rectus femoris, vastus later-
alis, vastus medialis, vastus intermedius), there were
significant difference between myositis and healthy groups,
consistent with those seen in the hamstrings and quadri-
ceps (Electronic Supplementary Material Table S1).
Muscle T2
Within the hamstrings, there was a difference of 7.9 ms
(95% CI: 3.9, 11.9 ms; p<0.001) between the myositis pa-
tients and healthy controls, representing a large effect size
(Cohen’s d¼0.80). Within the quadriceps, there was a dif-
ference of 11.7 ms (95% CI: 5.4, 17.9 ms; d¼0.88; p<0.001;
Fig 3).
T2 was inversely correlated with muscle strength mea-
surements in myositis and healthy controls in both the
quadriceps and the hamstrings (Fig 4).
Muscle FF
FF was higher in myositis patients compared to healthy
controls with a difference in the hamstrings of 6.6% (95% CI:
Figure 2 (a) ROC curve for quantitative MRI performance in discriminating myositis and healthy muscle. AUC hamstrings: T2 ¼ 0.941, MD ¼
0.535, FF ¼ 0.773; FA ¼ 0.543 Quadriceps: T2 ¼ 0.84, MD ¼ 0.547, FF ¼ 0.789; FA ¼ 0.652. (b) ROC curve for muscle volume and muscle strength
performance in discriminating myositis and healthy muscle. AUC: knee extension ¼ 0.785; knee flexion ¼ 0.824; muscle volume ¼ 0.746;
handgrip ¼ 0.910.
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(95% CI: 1.6%, 15.1%; d¼0.64; p¼0.01), representing
medium-to-large effect sizes (Fig 3). FF correlated with
muscle strength in the quadriceps with a correlation coef-
ficient of rs¼ e0.5 (p¼0.001) and weakly correlated in the
hamstrings rs¼0.3 (p¼0.08).Figure 3 Quantitative MRI measurements in 16 myositis patients compar
quantitative mean diffusivity; (d) quantitative FA.Muscle DTI
There was no significant difference in mean diffusivity
(MD) between the myositis patients and healthy controls in
the hamstrings (Fig 2), with a difference of 0.03103 mm2/
s (95% CI: e0.05, 0.06; d¼0.17; p¼0.5) or the quadriceps,ed to 16 healthy controls: (a) quantitative T2; (b) quantitative FF; (c)
Figure 4 Quantitative T2 measurements show substantive correlation with peak torque flexion (hamstrings) and extension (quadriceps) in 16
myositis patients and healthy controls in the (a) myositis patients hamstrings (rs¼e0.4; p¼0.1); (b) myositis patients quadriceps (rs¼e0.7;
p¼0.001); (c) healthy control hamstrings (rs¼e0.9; p<0.001); (d) healthy control quadriceps (rs¼e0.6; p¼0.02).
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d¼0.14; p¼0.6). There were no significant differences be-
tweenmyositis and healthy controls in fractional anisotropy
(FA) in the hamstrings with a difference of 0.02 (95% CI:
e0.01, 0.06; d¼0.2; p¼0.2) or quadriceps, with a difference
of 0.02 (95% CI: e0.01, 0.06; d¼0.1; p¼0.6).
In the small sub-analysis that investigated the contra-
dictory effects of fat and oedema on DTI measurements,
diffusion was found to be higher in the oedematous regions
and lower in the fatty regions.
Muscle volume
Patients had smaller muscle volumes than age- and
gender-matched healthy controls (Fig 5) with a difference of
e316 cm3 (95% CI e648 and e62 cm3; p¼0.01). Muscle
volume correlated with knee flexion torque (rs¼0.47) and
knee extension torque (rs¼0.63) in patients and healthy
controls combined (both p<0.001).
Comparison with radiologist scoring
Quantitative T2 correlated with the radiologists’ oedema
scores with rs¼0.7 in the hamstrings (p<0.001) and rs¼0.6
in the quadriceps (p<0.001), with an upward trend in T2 as
radiologist scored visible oedema increased (Fig 6). In a
separate comparison between the muscles in the myositis
patients who had been classified as unaffected by the ra-
diologists (n¼8), T2 values for patients were still higher
than those for age- and gender-matched healthy controls. Inthis subgroup analysis, the mean T2 in the hamstrings in
patients was 42.2 ms while healthy controls had a mean T2
of 38.7 ms, a difference of 3.5 ms (95% CI: 1.4, 5.5; p¼0.004).
In the quadriceps, the mean T2 in unaffected muscles of the
myositis patients (n¼8) was 43.9 ms and healthy controls
had a T2 of 40.1 ms, a difference of 3.8 ms (95% CI: 1.9, 5.6;
p¼0.001; Fig 7).
Within both the hamstrings and quadriceps, quantitative
FF correlatedwith radiologists’ scores for fatty infiltration at
rs¼0.79 in the hamstrings (p<0.001) and rs¼0.93 in the
quadriceps (p<0.001) with an upward trend in FF as radi-
ologist scored visible fatty infiltration increased (Fig 8). FF
values for patients with normal muscles according to radi-
ologists scoring were not substantively different to those for
healthy controls. In this subgroup analysis, the mean FF in
the hamstrings in patients was 3.4%, while healthy controls
had amean FF of 2.9%, a difference of 0.5% (95% CI:e1.6, 0.9;
p¼0.5). In the quadriceps, the mean FF in patients was 2.5%
and 2% in healthy controls, a difference of 0.5% (95% CI:
e0.9, 0.1; p¼0.1).
Discussion
The present study investigated the utility of quantitative
MRI as an indicator of active disease and muscle damage in
DM and PM patients compared with healthy controls. As
expected, there were significant differences in T2, FF, and
muscle volume between myositis patients and healthy
controls; however, differences in T2 remained significant
even when myositis patients who had been classed as
Figure 5 Quantitative muscle volume measurements, knee flexion and extension in 16 myositis patients compared to 16 healthy controls: (a)
muscle volume; (b) knee flexion; (c) knee extension.
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controls. This suggests that these measures may be a useful
non-invasive measure in the diagnosis and monitoring of
myositis. This is corroborated by the ROC analysis area AUC
values which, despite not being adequately powered,
demonstrate that T2 and FF could be useful in the diagnosis
of myositis, in particular T2, which is sensitive to bothFigure 6 T2 values grouped by radiologists’ oedema score compared w
moderate oedema; 3, severe oedema) and healthy controls: (a) hamstringsoedema and fatty infiltration, supporting previous work by
Ran et al.12
T2 was higher in myositis patients compared to healthy
controls, which is consistent with previous studies.10,29 This
may be due to the combined effects of increased fat (10,43),
inadequately suppressed by the SPAIR fat suppression, and
increased fluid due to inflammation.12 Although theith values in myositis patients (0, no oedema; 1, mild oedema; 2,
; (b) quadriceps. *Quadriceps had no grade 3 (severe oedema) scored.
Figure 7 T2 values of patients scored as having unaffected muscles matched with age, and gender-matched healthy controls.
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of increased fluid is contested. Although most papers, using
fat corrected T2 measurements, show increased T2 in
myositis.10,30 Schlaeger et al.31 found that T2 can decrease in
neuromuscular disease patients; however, their study
sample was heterogeneous including a range of muscular
diseases along with myositis.
In the present study, patient T2 values correlated with
radiologists’ visual scoring of muscle pathology, showing,
for the first time, that the changes in T2 agreed with
radiological assessment of active disease. The fact that the
eight myositis patients, classified as unaffected by radiolo-
gists, showed raised T2 compared to healthy controls sug-
gests that there is a certain threshold of muscle pathology
that is required before myositis can be detected visually on
conventional MRI sequences. This suggests that quantita-
tive T2 measurements could be used in conjunction with
the visual assessment of muscle to improve diagnosticFigure 8 FF values grouped by radiologist’s oedema score compared w
infiltration; 2, moderate fatty infiltration; 3, severe fatty infiltration): (a)
infiltration) scored.sensitivity. In particular, it suggests that relying on subjec-
tive assessment of sites of muscle inflammation by radiol-
ogists may fail to identify lower-grade inflammation in the
muscle and subtle changes in disease activity. It also means
that muscles classed as normal by the radiologist may still
be a useful target for diagnostic biopsy. Indeed, use of
quantitative measures may increase the number of sites
available for biopsy and identify sites that are technically
less challenging and safer for biopsy.
This study demonstrated for the first time that muscle
strength correlated with MRI T2, demonstrating that T2
relaxation times correlatewith the severity of the disease as
assessed by patient muscle strength; however, the rela-
tionship in the present study appears to be bimodal, rather
than a gradual linear degrading, giving the plots a charac-
teristic “L-shape”. This suggests that after a certain
threshold of T2, muscle strength deteriorates at a substan-
tive rate. Further work is needed to better characterise thisith values in myositis patients (0, no fatty infiltration; 1, mild fatty
hamstrings; (b) quadriceps. *Quadriceps had no grade 3 (severe fatty
M. Farrow et al. / Clinical Radiology 76 (2021) 81.e1e81.e10 81.e9relationship. In healthy individuals, T2 had a linear corre-
lation with muscle strength, and lower T2 values were
associated with increased strength.
The correlation between FF values and radiologists’
scores of fatty infiltration agrees with the literature.14 Pa-
tients’ FF values were higher in both the hamstrings and the
quadriceps compared to healthy controls, which is consis-
tent with the known fatty infiltration that occurs due to
myositis. This study showed for the first time that FF
correlated with muscle strength within the quadriceps and
the hamstrings in myositis patients. This supports previous
studies that have found an inverse relationship between
muscle strength and fatty infiltration in Duchennemuscular
dystrophy.32 This suggests that when fatty infiltration in-
creases due to myositis, muscle strength decreases, and this
can be identified by MRI FF.
There was a difference in muscle volume between
myositis patients and healthy controls and muscle volume
correlated with both knee extension and flexion torque in
both patients and healthy controls. This confirms thatmuscle
volume andmuscle strength are related, and thatmuscle loss
is apparent in myositis. This agrees with previous studies
that suggest that muscle volume is an important measure in
terms of muscle function, and that interventions such as
exercise to increase muscle mass might be beneficial for
function and to improve quality of life.33
DTI measurements showed no meaningful differences in
FA, eigenvalues, or MD between patients and healthy con-
trols, which is in disagreement with previously published
work by Ai et al.34 Given that T2 was higher in patients, one
might expect to see raised MD due to increased fluid;
however, increased cellularity and fatty infiltration, which
is known to occur in myositis, have been demonstrated to
restrict diffusion11
Ai et al.34 used small ROIs over diseased areas as opposed
to the ROIs in the present study depicting the entire muscle
(Fig 1). The differences in the present results could be due to
the competing influences of fat and water across the whole
muscle in the large ROIs whereas the measurements by Ai
et al. would be mainly dominated by reduced MD due to fat
in the small ROI focussed on the diseased area. The results
from the present sub-study, which utilised small ROIs,
support this theory, with an increase in MD in oedematous
regions, and a decrease inMD in fatty infiltrated regions,11,34
This study suggests that diffusion measurements can be
useful in the management of myositis, but should be used
with small ROIs due to the competing influence of fat and
oedema on the measurements.
The present study is subject to some limitations. This
study used SPAIR fat suppression, which only achieves
robust suppression with the main methylene and methyl
peaks. The olefinic fat peak (w10% of fat signal, T2 w 120
ms) will still contribute to the signal. Therefore, it is
important to understand that the present T2 measurements
will be affected by changes in both fluid and fat levels,
resulting in increased T2 values in heavily fat infiltrated
muscle.35,36 Advanced methods for separating fat from T2
measurements have been published in the literature33,34;
however, these are not widely available clinically.Conversely, the T2 measurements in the present study
could be carried out on any clinical MRI system without
advanced imaging or post-processing. Analysis of the FF, T2,
and diffusion measurements were only made on a single
section, raising the possibility of sampling variation if the
muscle changes were not homogeneous. Multi-echo se-
quences are known to overestimate T2 due to the formation
of stimulated echoes,28,37 but are widely used in practice to
keep scan times tolerably short for participants. The present
study only utilised six diffusion directions to decrease the
scan times, whereas 12 directions have been recommended
to reduce bias between the encoding and underlying tissue.
This could have limited the sensitivity of the present mea-
surements to changes in diffusion.38 More elegant analysis
methods that take the full extended phase graph into ac-
count have been used36,39,40; however, these methods are
complex and not easily available to clinical imaging. The
two-point Dixon imaging technique did not correct for T2*
effects, eddy currents, noise-related bias, or the spectral
complexity of fat. The muscle volume measurements did
not consider differences in shape and length of thigh
muscles between patients, although an attempt was made
to control for these differences by positioning relative to an
anatomical reference marker, similar to previous studies41;
however, work has also been published demonstrating the
validity of measuring total muscle volume using one section
as frequently reported.42 As T2, FF, and diffusion were only
measured on one section, some differences may be due to
differences in relative section position, rather than due to
disease induced differences alone.
In conclusion, the present study has demonstrated dif-
ferences inMRI T2, FF, andmuscle volume between patients
with DM and PM andmatched healthy controls. The present
results suggest that these measurements, in particular T2
and FF, could be used as an objective method to monitor
muscles. Furthermore, T2, FF, andmuscle volume correlated
with muscle function, demonstrating for the first time a
decrease in muscle function due to inflammation, myo-
steatosis, andmuscle atrophy. In addition, it was shown that
T2 measurements are sensitive to differences that may not
be detected by radiologists, potentially offering an
improvement in the ability of MRI to detect changes in
disease activity compared to reliance on subjective assess-
ment. The use of quantitative techniques may also identify
additional sites of muscle inflammation to target for diag-
nostic biopsy. This work will inform future efforts to vali-
date quantitative MRI measurements as a diagnostic and
management tool in myositis.
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